We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0YC0 market cap is 0. The company's latest EPS is USD -4.2158 and P/E is -0.36.
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 33k | 4.78M | 236k |
Operating Income | -79.47M | -91M | -91.3M | -56.67M | -57.57M |
Net Income | -76.4M | -82.18M | -93.84M | -60.73M | -59.93M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 181.38M | 151.22M | 156.32M | 124.71M | 124.35M |
Total Liabilities | 20.68M | 30.51M | 73.44M | 65.14M | 57.5M |
Total Equity | 160.69M | 120.71M | 82.88M | 59.57M | 66.85M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -56.62M | -72.42M | -78.33M | -45.06M | -51.03M |
Investing | -72.21M | 67.95M | -5.21M | 39.31M | -24.55M |
Financing | 136.93M | 27.44M | 63.88M | 20.85M | 54.86M |
Market Cap | 0 |
Price to Earnings Ratio | -0.36 |
Price to Sales Ratio | 90.36 |
Price to Cash Ratio | 1.67 |
Price to Book Ratio | 0.32 |
Dividend Yield | - |
Shares Outstanding | 14.22M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0%) |
Company Name | Unity Biotechnology Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.unitybiotechnology.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions